0 CHECKOUT

High Content Screening (HCS) - Global Strategic Analysis

  • ID: 2228034
  • February 2016
  • Region: Global
  • 202 Pages
  • Global Industry Analysts, Inc
1 of 3

This report analyzes the worldwide markets for High Content Screening (HCS) in US$ Million. The Global market is further analyzed by the following Segments: Consumables, Instruments, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.

Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 73 companies including many key and niche players such as:

BD Biosciences
BioTek Instruments Inc.
Definiens AG
EMD Millipore
Evotec AG

Note: Product cover images may vary from those shown
2 of 3

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Consumables
Instrumentation
Others
Software
Services

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
HCS
An Evolving Screening Technology
HCS Market Ripe with Growth Opportunity
Key Growth Drivers
Key Challenges
Market Outlook
Developing Regions Drive Future Growth
Table 1: Global High Content Screening (HCS) Market
Geographic Regions Ranked by CAGR for 2014-2020 (includes corresponding Graph/Chart)
HCS Software
A High Growth Market
Equipment Sales Continue to Expand
Recession in Pharma Industry Hits Prospects for Consumables and Instruments
Competitive Overview
Focus on Key Players in the HCS Market
BD Biosciences
Thermo Fisher Scientific Inc.
GE Healthcare
PerkinElmer Inc.
Table 2: Leading Players in the Global HCS Market (2015E): Percentage Share Breakdown for BD Biosciences, GE Healthcare, PerkinElmer, Molecular Devices, Thermo Fisher Scientific, Thorlabs, and Others (includes corresponding Graph/Chart)
Venture Capital Investments Continue to Grow

2. MARKET TRENDS AND ISSUES
HCS
Evolves as Primary Screening Method
Table 3: Global Screening Market (2014): Percentage Share Breakdown by Segment
Primary Screening, Secondary Screening and Leads-to-Candidate (ADME/Tox Screening) (includes corresponding Graph/Chart)
Technology Advancements Spearhead Market Growth
Government Support Bodes Well for the Market
Emergence of Academic Sector as the Major User of HCS
Table 4: HCS Budget of a Typical Research Company (includes corresponding Graph/Chart)
Table 5: Global High-Throughput Screening Market (2015): Percentage Breakdown of Sales by End-use Segment (includes corresponding Graph/Chart)
Stem Cell Biology
An Emerging Area of Interest
HCS Specific Data Analysis Systems
The Need of the Hour
HCS vs. HTS
Rise in Adoption of HCS Technology in HTS Laboratories
Market Challenges
High Instrumentation Costs Hamper Rapid Growth

3. PRODUCT OVERVIEW
Defining High Content Screening
The Process of High Content Screening
The Process of High Content Screening
Technology Evolves Over the Years
HCS Tools
List of HCS Tools
HCS Imaging
Categories
Instrumentation
Consumables
Software
Services

4. PRODUCT INTRODUCTIONS/INNOVATIONS
Molecular Devices Launches New ImageXpress® Micro Confocal HCS
CYTOO Launches MyoScreen?™ Platform
Molecular Devices Unveils EarlyTox™ Cell Viability Assay Kits
Molecular Devices Introduces FLIPR® Potassium Assay Kit
IntelliCyt Unveils iQue® Screener PLUS
BioTek Launches Cytation™ 5 Cell Imaging Multi-Mode Reader
Genedata Launches Genedata Screener® 12
Thermo Fisher Scientific Introduces New CeLLInsight CX5 HCS Platform
PerkinElmer Introduces Opera Phenix™ Next-Gen HCS System
Molecular Devices Unveils ImageXpress® Micro XLS System
TMO Unveils HCS Studio Software
Molecular Devices Launches FLIPR® Calcium 6 Assay Kits
TMO Expands its HCS Portfolio with Three New Products
Cytoo Introduces 2D+ Solutions
TTP Labtech Unveils Acumen High Content Imaging System

5. RECENT INDUSTRY ACTIVITY
Genedata Forms Alliance with IntelliCyt
Harlan Inks Strategic Partnership with Fluofarma
BioTech Inks Distribution Agreement with IDEA Bio-Medical

6. FOCUS ON SELECT GLOBAL PLAYERS
BD Biosciences (US)
BioTek Instruments Inc. (US)
Definiens AG (Germany)
EMD Millipore (US)
Evotec AG (Germany)
Essen BioScience (US)
Fluxion Biosciences, Inc. (US)
GE Healthcare Life Sciences (Sweden)
Genedata AG (Switzerland)
IntelliCyt Corporation (US)
Molecular Devices Inc. (US)
PerkinElmer Inc. (US)
Roche Applied Sciences (Germany)
Thermo Fisher Scientific, Inc. (US)
Thorlabs, Inc. (US)
TTP LabTech Ltd. (UK)
Yokogawa Electric Corporation (Japan)

7. GLOBAL MARKET PERSPECTIVE
Table 6: World Recent Past, Current & Future Analysis for High Content Screening by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 7: World Historic Review for High Content Screening by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 8: World 14-Year Perspective for High Content Screening by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 9: World Recent Past, Current & Future Analysis for High Content Screening by Segment
Consumables, Instruments, and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 10: World Historic Review for High Content Screening by Segment
Consumables, Instruments, and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 11: World 14-Year Perspective for High Content Screening by Segment
Percentage Breakdown of Revenues for Consumables, Instruments, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Market Overview
Product Launches
Recent Industry Activity
Key Players
B.Market Analytics
Table 12: US Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 13: US Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA
Market Analysis
Table 14: Canadian Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 15: Canadian Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Outlook
Yokogawa Electric Corporation
A Key Player
B.Market Analytics
Table 16: Japanese Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 17: Japanese Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Outlook
Clinical Trials Market in Europe
B.Market Analytics
Table 18: European Recent Past, Current & Future Analysis for High Content Screening by Geographic Region
France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 19: European Historic Review for High Content Screening by Geographic Region
France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 20: European 14-Year Perspective for High Content Screening by Geographic Region
Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE
A.Market Analysis
Outlook
Corporate Development
Fluofarma SA
A Key Player
B.Market Analytics
Table 21: French Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 22: French Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY
A.Market Analysis
Outlook
Key Players
B.Market Analytics
Table 23: German Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 24: German Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4c. ITALY
A.Market Analysis
Outlook
B.Market Analytics
Table 25: Italian Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 26: Italian Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM
A.Market Analysis
Outlook
Product Launch
Key Players
B.Market Analytics
Table 27: The UK Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 28: The UK Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4e. SPAIN
A.Market Analysis
Outlook
B.Market Analytics
Table 29: Spanish Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 30: Spanish Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4f. REST OF EUROPE
A.Market Analysis
Outlook
Product Launch
Strategic Corporate Development
Key Players
B.Market Analytics
Table 31: Rest of Europe Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 32: Rest of Europe Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Outlook
Select Regional Analysis
China
China Emerges as the Major Outsourcer for Drug Discovery
India
B.Market Analytics
Table 33: Asia-Pacific Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 34: Asia-Pacific Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. REST OF WORLD
Market Analysis
Table 35: Rest of World Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 36: Rest of World Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 73 (including Divisions/Subsidiaries 80)
The United States (36)
Japan (3)
Europe (36)
- France (6)
- Germany (9)
- The United Kingdom (10)
- Italy (1)
- Spain (1)
- Rest of Europe (9)
Asia-Pacific (Excluding Japan) (3)
Middle East (2)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-10 user licence, allowing up to ten users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • CSL Limited
  • Novartis AG
  • Qiagen N.V.
  • Quintiles Transnational
  • Roche Diagnostics Ltd.